Pomegranate Peel Extract 40%-90% Ellagic Acid
Pomegranate Peel Extract 40%-90% Ellagic Acid
Product name: Pomegranate Extract (Ellagic Acid)
Part used: Peel
Appearance: Grey-brown powder
CAS No.: 90045-46-8
Specification: Ellagic Acid 40%-90%
Molecular formula: C14H6O8
Pomegranate Extract has antioxidant, anti-mutagen and anti-cancer properties. Studies have shown the anti-cancer activity on cancer cells of the breast, oesophagus, skin, colon, prostate and pancreas. More specifically, Pomegranate Extract prevents the destruction of P53 gene by cancer cells. Pomegranate Extract can bind with cancer causing molecules, thereby making them inactive. The effects of dietary Pomegranate Extract on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes.Ahn D et al showed that Pomegranate Extract causes a decrease in total hepatic mucosal cytochromes and an increase in some hepatic phase II enzyme activities, thereby enhancing the ability of the target tissues to detoxify the reactive intermediates. Pomegranate Extract showed also a chemoprotective effect against various chemically induced cancers.
Pomegranate Extract d has also been said to reduce heart disease, birth defects, liver problems, and to promote wound healing.
Function:
Ellagic Acid, the active ingredient extracted from Punica granatum L,has the following functions:
1) Anti-cancer and anti-mutation. It has been proved to be an effective anti-carcinogen upon carcinoma of rectum and colon,esophageal carcinoma, liver cancer, lung cancer, carcinoma of tongue and skin.
2)Restrain to human immunodeficiency virus (HIV) and many kinds of microbe and virus.
3) Antioxidant, coagulant, descenting blood pressure and sedation.
4) Treat kinds of symptoms caused by high blood sugar, hypertension.
5) Resist to atherosclerosis and tumour.
6) Resist to antioxidance, senescence inhibition and skin whitening.
Application:
Cosmetic field
Applied in cosmetic field,it is added in various skin care products for its anti-inflammatory and antioxidative action.
Health product & pharmaceutical field
Applied in health product & pharmaceutical field, As a functional factor such as anti-oxidation, inhibition of human immunodeficiency virus, skin whitening.
COA and other ceitificates will be sent under request.
| Package |
carton drum with two plastic bags inside |
| Net weight |
25KG/Drum |
| Storage |
Sealed in cool and dry place to avoid moisture and light |
| Shelf life |
2 years when properly stored |
| Lead time |
1~3 days after confirmation |
Item
|
Specification
|
Result |
Method |
| Ellagic acid |
40% |
40.25% |
UV |
| Organoleptic |
| Appearance |
Light grayish powder |
Light grayish powder |
Visual |
| Odor |
Characteristic |
Characteristic |
Organoleptic |
| Taste |
Characteristic |
Characteristic |
Organoleptic |
| Physical Characteristics |
| Particle Size |
100%Through 80 mesh |
Complies |
USP < 786 > |
| Loss on Drying |
≤5.00% |
2.85% |
USP |
| Ash content |
≤5.00% |
2.13% |
3h at 600ºC |
| Heavy metals |
|
|
|
| Irradiation detection |
Not irradiated(PPSL<700) |
Complies |
PPS L(CQ-MO-572) |
| Allergen detection |
Non ETO Treated |
Complies |
USP |
| Heavy metals(as Pb) |
USP standards(<10ppm) |
<10ppm |
USP < 231 > |
| Arsenic (As) |
≤3ppm |
Complies |
ICP-OES(CQ-MO-247) |
| Lead (Pb) |
≤2ppm |
Complies |
ICP-OES(CQ-MO-247) |
| Cadmium(Cd) |
≤1ppm |
Complies |
ICP-OES(CQ-MO-247) |
| Mercury(Hg) |
≤0.1ppm |
Complies |
ICP-OES(CQ-MO-247) |
| Pesticide Residue |
Non-detected |
Non-detected |
USP < 561 > |
| Microbiological Tests |
| Total Plate Count |
NMT1000cfu/g |
Complies |
FDA-BAM |
| Total Yeast & Mold |
NMT100cfu/g |
Complies |
FDA-BAM |
| E.Coli |
Negative |
Negative |
FDA-BAM |
| Salmonella |
Negative |
Negative |
FDA-BAM |
| Conclusion |
Complies to the above requirements. |
| Packing and Storage |
25kg carton drum;Stored in a well-closed container in cool and dry,away from sunlight and moisture. |
Audited Supplier 
){kind=link}
){kind=link}